AFP and neoplasm: Conversely, in the low-tumor-marker group (post-treatment AFP ≤ 10 ng/mL), AFP levels decreased slightly from 2.8 ng/mL to 2.1 ng/mL, but this change was not statistically significant (p = 0.552).